NO923581L - Sykliske substituerte imidazolylpropensyrederivater - Google Patents

Sykliske substituerte imidazolylpropensyrederivater

Info

Publication number
NO923581L
NO923581L NO92923581A NO923581A NO923581L NO 923581 L NO923581 L NO 923581L NO 92923581 A NO92923581 A NO 92923581A NO 923581 A NO923581 A NO 923581A NO 923581 L NO923581 L NO 923581L
Authority
NO
Norway
Prior art keywords
acid derivatives
imidazolylpropenic
cyclic substituted
propenoic acid
substituted imidazolyl
Prior art date
Application number
NO92923581A
Other languages
English (en)
Norwegian (no)
Other versions
NO923581D0 (no
Inventor
Thomas Kraemer
Juergen Dressel
Rudolf Hanko
Walter Huebsch
Ulrich Mueller
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Johannes-Peter Stasch
Andreas Knorr
Stefan Wohlfeil
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO923581D0 publication Critical patent/NO923581D0/no
Publication of NO923581L publication Critical patent/NO923581L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO92923581A 1991-10-01 1992-09-15 Sykliske substituerte imidazolylpropensyrederivater NO923581L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4132633A DE4132633A1 (de) 1991-10-01 1991-10-01 Cyclisch substituierte imidazolyl-propensaeurederivate

Publications (2)

Publication Number Publication Date
NO923581D0 NO923581D0 (no) 1992-09-15
NO923581L true NO923581L (no) 1993-04-02

Family

ID=6441875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923581A NO923581L (no) 1991-10-01 1992-09-15 Sykliske substituerte imidazolylpropensyrederivater

Country Status (14)

Country Link
US (1) US5225428A (zh)
EP (1) EP0535465A1 (zh)
JP (1) JPH05213937A (zh)
KR (1) KR930007938A (zh)
AU (1) AU646762B2 (zh)
CA (1) CA2079266A1 (zh)
CZ (1) CZ297792A3 (zh)
DE (1) DE4132633A1 (zh)
HU (1) HUT62578A (zh)
IL (1) IL103292A0 (zh)
MX (1) MX9205434A (zh)
NO (1) NO923581L (zh)
TW (1) TW206966B (zh)
ZA (1) ZA927499B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
WO1995026188A1 (en) * 1994-03-29 1995-10-05 Merck & Co., Inc. Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
US6465502B1 (en) * 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
US20090111994A1 (en) * 2005-02-03 2009-04-30 Ratiopharm Gmbh Method for The Production of Losartan
EP1741711A1 (en) * 2005-07-04 2007-01-10 KRKA, D.D., Novo Mesto A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1H-imidazole-5-carbaldehydes
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CN107325052B (zh) * 2017-06-19 2020-01-10 广东药科大学 一类具有抗癌活性的咪唑酯类化合物及其衍生物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
DE69034103T2 (de) * 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
HU217958B (hu) * 1989-06-30 2000-05-28 E. I. Du Pont De Nemours And Co. Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
JP2568315B2 (ja) * 1989-06-30 1997-01-08 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 縮合環アリール置換イミダゾール
CA2027937A1 (en) * 1989-10-25 1991-04-26 Richard M. Keenan Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
GB9017482D0 (en) * 1990-08-09 1990-09-26 Ici Plc Manufacturing process
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate

Also Published As

Publication number Publication date
ZA927499B (en) 1993-05-03
CA2079266A1 (en) 1993-04-02
DE4132633A1 (de) 1993-04-08
AU2602592A (en) 1993-04-08
KR930007938A (ko) 1993-05-20
AU646762B2 (en) 1994-03-03
EP0535465A1 (de) 1993-04-07
JPH05213937A (ja) 1993-08-24
TW206966B (zh) 1993-06-01
CZ297792A3 (en) 1993-04-14
NO923581D0 (no) 1992-09-15
HU9203125D0 (en) 1992-12-28
HUT62578A (en) 1993-05-28
IL103292A0 (en) 1993-02-21
US5225428A (en) 1993-07-06
MX9205434A (es) 1993-04-01

Similar Documents

Publication Publication Date Title
NO923581L (no) Sykliske substituerte imidazolylpropensyrederivater
DE60025328D1 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
DE69630455D1 (de) PRODUKTION VON BETA -GLUKAN-MANNAN PRÄPARATIONEN MITTELS AUTOLYSE VON ZELLEN UNTER BESTIMMTEN pH-, TEMPERATUR- UND ZEIT BEDINGUNGEN
ATE177421T1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
DK1373543T3 (da) Fremgangsmåde til fremstilling af pektinhydrolyseprodukter
NO942211L (no) Acylerte sitratestere som persyreprecursorer
FI960281A0 (fi) Menetelmä tuotteiden sterilisoimiseksi
ES2147551T3 (es) Procedimiento para transformar plantas monocotiledoneas.
NO167498C (no) Behandlet, halvgjennomtrengelig polymermembran, fremgangsmaate for fremstilling derav og anvendelse av membranen.
EA199800288A1 (ru) Производные 5-o-дезозаминил-6-o-метилэритронолида а, способ их получения и их применение для получения биологически активных продуктов
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
ATE297750T1 (de) Verwendung von hsp70 protein
WO2002011782A8 (es) Metodo de produccion de filmes a base de quitosan con capacidad de adherencia celular aumentada, producto obtenido y aplicaciones
NO305868B1 (no) Alginat-oligosakkarid, framgangsmÕte for framstilling av alginat-oligosakkarid i blodtrykksendende nµringsmiddel
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
IT1243987B (it) Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono
DE60104687D1 (de) Mikrofiltration unter verwendung von aktivkohle
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
IT8222840A0 (it) Derivati di amino e diamino-acidi, loro procedimento di produzione eloro impiego come stimolanti di crescita delle piante e come prodotti farmaceutici.
NO20031261L (no) Dyrefôrsupplement som inneholder D-pantotensyre og/eller dens salter, forbedret fremgangsmåte for fremstilling derav samt anvendelse derav
NO880437L (no) Fremgangsmaate og innretning til behandling av stoffer og/eller mikroorganismer med elektroimpulser.
NO20022361L (no) Fremgangsmåte for fremstilling av konjugert linolsyre
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister